A farmer in China followed an AI chatbot’s treatment plan for sesame crops, using the herbicide flufenacet in a highly targeted yet misapplied manner that destroyed about 25 acres of sesame seedlings, underscoring the risks of relying on AI advice without verification.
A Chinese farmer followed a chatbot’s weed- and pest-control instructions, applying a chemical not suited for sesame across his entire field and losing about 24.7 acres of his sesame crop. The AI later acknowledged the mistake, highlighting that AI advice can be wrong and should be independently verified.
Costco has launched a $179 three-month weight loss program in partnership with healthcare provider Sesame, offering prescriptions for weight loss drugs like Ozempic. The program includes a video consultation with a weight loss doctor, ongoing support, and unlimited messaging, with the possibility of receiving a GLP-1 prescription if appropriate. This move comes as obesity rates continue to rise, with research suggesting that around 9 percent of the US population could be taking GLP-1 drugs by 2030. Costco's initiative follows a trend of big-box retailers, such as Amazon and Walmart, expanding into healthcare services.
Costco Wholesale is expanding its partnership with online healthcare services provider Sesame to offer weight-loss programs, including access to prescription drugs Ozempic and Wegovy, to its members. The program, priced at $179 for three months for members, involves clinician support for diet, exercise, and lifestyle modifications, with the possibility of medication subscription. Demand for GLP-1 agonists, a class of diabetes and obesity drugs, has been on the rise. This move comes as big-box retailers like Amazon and Walmart have been venturing into healthcare services, with Amazon offering virtual primary care and Walmart running primary care centers at its stores.
Costco is now offering its U.S. members access to prescriptions for GLP-1 weight loss drugs through its partnership with Sesame, a direct-to-consumer healthcare marketplace. Members can subscribe to Sesame’s weight loss program for as low as $179 per subscription period, which includes clinical consultations and access to medications like Wegovy and Ozempic. This new program aims to provide affordable access to medically supervised weight loss interventions and addresses the increasing popularity of GLP-1 weight loss drugs in recent years.
Costco is expanding its partnership with Sesame to offer exclusive pricing on weight loss programs, including a three-month subscription at a discounted rate of $179 for members. The program includes a live video consultation with a weight loss doctor, guidance on nutrition and exercise, and the potential prescription of weight loss medicines like Ozempic or Wegovy. However, the cost of the medicine is not included in the base price, and pharmacies have reported shortages of these drugs. This move follows similar weight loss services offered by rivals Amazon and Weight Watchers, and aims to make high-quality specialty care more accessible and affordable for Costco members.
Costco is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its healthcare partner Sesame, which includes a renewable three-month program with video consultations, prescriptions, and ongoing support. The cost of medication is not included in the $179 three-month plan, and without insurance, GLP-1s can cost between $950 and $1,600 per month. This move aims to address the growing interest in weight loss medications among various demographics, with other companies like WeightWatchers and luxury gyms also entering the space.
Costco has introduced a subscription-based weight loss program in partnership with healthcare provider Sesame, offering access to prescription weight-loss drugs for members and non-members. The program, priced at $179 for members and $195 for non-members, includes three months of clinical consultation, video consultations, nutritional guidance, and access to GLP-1 prescription weight-loss drugs. Sesame claims it to be the most affordable weight loss program in the US, with the potential for patients to lose 5-15% of their body weight within a year. This move follows the trend of retailers offering remote access to healthcare providers, with Amazon and Walmart also entering the space.
Costco has partnered with Sesame to offer a weight loss program for its members, providing access to medications from pharmaceutical companies like Eli Lilly and Novo Nordisk. For $179, members can receive three months of clinical consultation and other services, including prescriptions for popular weight loss drugs. This expanded partnership aims to make high-quality specialty care more accessible and affordable, with a focus on individualized care plans. Other companies, such as WeightWatchers, are also targeting consumers using weight loss-related medications, emphasizing tailored behavioral support.
Costco is teaming up with healthcare marketplace Sesame to offer eligible members access to a weight-loss program that includes clinically approved GLP-1 prescription drugs like Ozempic for $179 for three months. This program, aimed at the uninsured and those with high deductibles, provides consultations with a clinician and a medically appropriate treatment plan. The move follows Costco's previous partnership with Sesame offering virtual primary care, and reflects a trend of big-box retailers entering the healthcare space.
Costco is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its health care partner Sesame, with a three-month program that includes a video consultation with a weight loss doctor or specialist, a GLP-1 or weight loss prescription, if appropriate, and ongoing support through unlimited messaging and guidance with a health care provider. The cost of medication is not included in the $179 three-month plan, and without insurance, GLP-1s can cost between $950 and $1,600 per month. This move comes as the use of GLP-1 drugs for weight loss is on the rise, with other companies and providers also entering the market to offer these medications and related services. JPMorgan researchers estimate that 30 million people may be taking GLP-1 drugs by 2030, or around 9% of the US population.
Costco is now offering its U.S. members access to weight loss prescriptions through a partnership with Sesame, a direct-to-consumer healthcare marketplace, for as low as $179 per subscription period. The program includes three months of clinical consultation, the ability to select a clinician, live video consultations, messaging with the clinician, a nutritional guide, and individualized treatment programs. Non-members can also access the subscription for $195 per period. This initiative comes as a response to customer interest in weight loss, and is part of Costco's broader partnership with Sesame to offer outpatient medical care.
Costco is now offering its members prescriptions for weight loss drugs such as Ozempic and Wegovy through its health care partner Sesame, with a three-month subscription costing $179 for members and $195 for non-members. However, the high demand for these medications has led to shortages, with pharmaceutical companies like Eli Lilly and Novo Nordisk struggling to meet the overwhelming demand. Novo Nordisk has even acquired facilities in an $11 billion deal to address the shortage, but the gap between demand and supply is significant enough to take years to close.
Costco is teaming up with Sesame, a healthcare marketplace, to offer its members in the U.S. access to a weight loss program for $179 every three months starting April 2. The program includes clinical consultation, the ability to choose a clinician, live video consultations, messaging with the clinician, nutritional guidance, and individualized treatment plans. Sesame also offers virtual health visits and mental health therapy through Costco, and may provide weight loss medication prescriptions when clinically appropriate. Sesame is available to consumers with or without Costco memberships, and primarily offers virtual care with some in-person options.
M&P Production LTD is recalling 670 pounds of raw meat products in four states due to the misbranding of an undeclared allergen, sesame seeds, which can be life-threatening for those allergic. Another New York company, MF Meats, is recalling over 93,000 pounds of raw meat products due to potential contamination with non-food grade mineral seal oil. The USDA is urging operators not to serve these products and there have been no confirmed reports of adverse reactions due to consumption of the affected products.